Acanthosis Nigricans: An Updated Review.
Leung AKC, Lam JM, Barankin B, Leong KF, Hon KL.
Curr Pediatr Rev. 2022;19(1):68-82. doi: 10.2174/1573396318666220429085231.
Acanthosis nigricans: A review.
Das A, Datta D, Kassir M, Wollina U, Galadari H, Lotti T, Jafferany M, Grabbe S, Goldust M.
J Cosmet Dermatol. 2020 Aug;19(8):1857-1865. doi: 10.1111/jocd.13544.
Acanthosis nigricans.
[No authors listed]
Pediatr Dermatol. 2022 Mar;39(2):295-296. doi: 10.1111/pde.14973.
Acanthosis nigricans.
Stuart CA, Driscoll MS, Lundquist KF, Gilkison CR, Shaheb S, Smith MM.
J Basic Clin Physiol Pharmacol. 1998;9(2-4):407-18. doi: 10.1515/JBCPP.1998.9.2-4.407.
Acanthosis nigricans.
Sedano HO, Gorlin RJ.
Oral Surg Oral Med Oral Pathol. 1987 Apr;63(4):462-7. doi: 10.1016/0030-4220(87)90259-3.
Acanthosis nigricans and the metabolic syndrome.
Karadağ AS, You Y, Danarti R, Al-Khuzaei S, Chen W.
Clin Dermatol. 2018 Jan-Feb;36(1):48-53. doi: 10.1016/j.clindermatol.2017.09.008. Epub 2017 Sep 8.
Malignant acanthosis nigricans and diseases with extensive oral papillary hyperplasia.
Liu Y, Xu X, Yang Y, Hu H, Jiang X, Xiong X, Meng W.
Clin Exp Dermatol. 2022 Apr;47(4):651-657. doi: 10.1111/ced.14995. Epub 2021 Dec 7.
Drug-induced acanthosis nigricans: A systematic review and new classification.
Mourad AI, Haber RM.
Dermatol Ther. 2021 Mar;34(2):e14794. doi: 10.1111/dth.14794. Epub 2021 Feb 4.
Malignant Acanthosis Nigricans.
Wang HJ, Hu SC.
N Engl J Med. 2023 Mar 16;388(11):1031. doi: 10.1056/NEJMicm2207017.
Juvenile acanthosis nigricans.
Sinha S, Schwartz RA.
J Am Acad Dermatol. 2007 Sep;57(3):502-8. doi: 10.1016/j.jaad.2006.08.016. Epub 2007 Jun 25.
